Organogenesis gets second Apligraf approval

The FDA granted marketing approval of ORG's Apligraf living, bi-layered skin substitute to treat diabetic foot ulcers. Novartis (SWX:NOVN; NVS) has worldwide marketing rights to the product, which als...